The first and only FDA-cleared molecular Trichomonas vaginalis test for both women and men

The use of highly sensitive and specific tests is recommended for detecting T. vaginalis. Among women, NAAT is highly sensitive, often detecting three to five times more T. vaginalis infections than wet-mount microscopy, a method with poor sensitivity (51%–65%).”

The Need

According to the Centers for Disease Control and Prevention (CDC), Trichomonas vaginalis (TV) is the most prevalent nonviral sexually transmitted infection in the United States, affecting an estimated 2.3M women and 1.4M men.1,2

TV is associated with:

Two to threefold increased risk for HIV acquisition1

Preterm birth and other adverse pregnancy outcomes in women1

Urethritis, epididymitis, or prostatitis in men1

NAAT (nucleic acid amplification testing) is recommended by the CDC and is often 3 to 5 times more sensitive than wet mount microscopy.1